NCT03360708View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 27, 2013

Primary Completion Date

June 2, 2021

Study Completion Date

June 2, 2021

Conditions

Giant Cell GlioblastomaRecurrent GlioblastomaRecurrent Gliosarcoma

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

Given ID

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER